Repurposing Drugs in Oncology (ReDO)—mebendazole as an anti-cancer agent

Mebendazole, a well-known anti-helminthic drug in wide clinical use, has anti-cancer properties that have been elucidated in a broad range of pre-clinical studies across a number of different cancer types. Significantly, there are also two case reports of anti-cancer activity in humans. The data are...

Descripción completa

Detalles Bibliográficos
Autores principales: Pantziarka, Pan, Bouche, Gauthier, Meheus, Lydie, Sukhatme, Vidula, Sukhatme, Vikas P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096024/
https://www.ncbi.nlm.nih.gov/pubmed/25075217
http://dx.doi.org/10.3332/ecancer.2014.443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096024/
https://www.ncbi.nlm.nih.gov/pubmed/25075217
http://dx.doi.org/10.3332/ecancer.2014.443

Ejemplares similares